Redfin (RDFN) shares soared 80% pre-bell Monday after the company agreed to be acquired by Rocket Companies (RKT) in a deal worth $1.75 billion.
Checkpoint Therapeutics (CKPT) shares surged 67% after the company agreed to be acquired by India's Sun Pharmaceutical Industries for $4.10 per share in cash plus a contingent value right.
Trevi Therapeutics (TRVI) shares advanced 32% after the company said its phase 2a trial of Haduvio for the treatment of patients with refractory chronic cough met its primary endpoint.